Phase <scp>II</scp> study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: <scp>DSMM XI</scp> trial
Hermann Einsele(Universitätsklinikum Würzburg), Stefan Knop(University of Tübingen), Bernd Metzner(Klinikum Oldenburg), Wolf Rösler, Georg Heß(Johannes Gutenberg University Mainz), Michael Pfreundschuh(Saarland University), Holger Hebart, Heinz Dürk(St. Marien Hospital), Christoph Tapprich(Johnson & Johnson (Germany)), Jürgen Müller(Mecachrome (France)), Bernd Hertenstein(San Antonio College), Elke Jäger(Krankenhaus Nordwest), Martin Gramatzki(University Hospital Schleswig-Holstein), Christian Straka, Monika Engelhardt(University Medical Center Freiburg), Wolfram Jung(University of Göttingen), Hans Salwender(Asklepios Klinik Altona), Georg Maschmeyer(Radboud University Medical Center), Peter Liebisch(Universität Ulm), Hans‐Heinrich Wolf(University Hospital in Halle), Lars O. Mügge(Jena University Hospital), Thomas Fischer(University Hospital Magdeburg), Lothar Kanz(University of Freiburg), Martin Bentz(Städtisches Klinikum Karlsruhe), Martin Kropff(University Hospital Münster), Christina Hart(University Hospital Regensburg), Christian Langer(University Hospital Ulm)
Cited by 30
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k